New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2013
10:05 EDTCTASCintas breaks down below its 10-day MA after results, levels to watch
The stock is down over 5.8% at time of writing, last at $43.25. At that price, the stock is now below its 10-day moving average, last at $44.59 and now resistance. Next support is at $42.71 and then at $42.31. The company missed expected earnings for its Q3 when it reported last night after the close by a penny. The company set guidance for its fiscal year 2013 earnings to a range of $2.50 to $2.54 versus consensus of $2.55.
News For CTAS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 19, 2015
10:23 EDTCTASHigh option volume stocks
Subscribe for More Information
March 18, 2015
18:32 EDTCTASOn The Fly: After Hours Movers
UP AFTER EARNINGS: Guess (GES), up 12.4% after reporting fourth quarter results and guidance... Shoe Carnival (SCVL), up 10%... NQ Mobile (NQ), up 9.1%... Tilly's (TLYS), up 1.3%... Cintas (CTAS), up 1.3% after reporting quarterly results and raising fiscal 2015 guidance. DOWN AFTER EARNINGS: Williams-Sonoma (WSM), down 4.1%... Jabil Circuit (JBL), down 1.8%... Juno Therapeutics (JUNO), down 3.3%. ALSO LOWER: Concert Pharmaceuticals (CNCE), down 4.4% after filing to sell common stock... Tekmira Pharmaceuticals (TKMR), down 3.7% after filing to sell 6M shares of common stock.
17:01 EDTCTASCintas raises FY15 EPS view to $3.31-$3.34 from $3.20-$3.25, consensus $3.27
Subscribe for More Information
16:31 EDTCTASCintas sees FY15 EPS $3.31-$3.34, consensus $3.27
Subscribe for More Information
16:27 EDTCTASCintas reports Q3 EPS 85c, consensus 78c
Reports Q3 revenue $1.11B, consensus $1.11B.
15:20 EDTCTASNotable companies reporting after market close
Subscribe for More Information
March 17, 2015
11:37 EDTCTASCintas March volatility elevated into Q3 and outlook
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use